Resistance to etoposide, which was expressed following exposure of a human tumour cell line (HN-I) to fractionated X-irradiation (II fractions to a total dose of 50Gy), was found to be exhibited after delivery of only 5 fractions (total dose of 22.5Gy). In addition, 2 new etoposide-resistant subline
In vitro responses of human prostate tumour cell lines to a range of antitumour agents
โ Scribed by Sylvia A. Metcalfe; Richard D. H. Whelan; John R. W. Masters; Bridget T. Hill
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- French
- Weight
- 800 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Four human prostate tumour continuous cell lines were employed for in vitro drug sensitivity testing of nine cytotoxic drugs, Xโirradiation and two hormonal preparations. Responses were assessed by measuring cell survival as judged by colony formation in agarose. A marked heterogeneity of responses was noted to many of the agents studied, including Xโirradiation. However, in terms of ID~70~ values for 24โh drug exposures, comparable responses in all the cell lines tested, with values falling within a 1.4โ to 2.9โfold range, were noted with actinomycin D, adriamycin, mโAMSA^4^, dibromodulcitol, 5โfluorouracil, hydroxyurea and ICRFโ159. In contrast, mixed responses to cisโplatinum and methotrexate were particularly marked, with ID~70~ values differing by factors of 3.8 and 7.5 respectively. In addition, when higher drug concentrations of mโAMSA, cisโplatinum, dibromodulcitol and ICRFโ159 were employed, significant deviations in the four survival curves became apparent. Continuous exposure to diethylstilboestrol and medroxyprogesterone acetate caused negligible cell kill. Due to these variable responses it was not possible to predict that any agent tested might have specific value in the treatment of prostate cancer. However, preliminary in vitro screening with such a panel of cell lines may complement in vivo studies with models of prostatic cancer and prove useful in investigations of mechanisms of drug resistance.
๐ SIMILAR VOLUMES
Autocrine growth factors for the epidermal growth factor receptor (EGFR) have been identified in prostate tumors, implicating a role for EGFR in the progression of prostate cancer. To investigate early signaling mechanisms used by the EGFR in prostate tumor cells, we have characterized the involveme
Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line
BACKGROUND. The possibility was investigated that complex homeostatic mechanisms which maintain polyamine pools in prostate-derived tumors may differ from those which are typically seen in other tissues and tumors. METHODS. Growth sensitivity and various regulatory responses were investigated in thr
A non-tumorigenic epithelial cell line designated PCIAA, derived from a large pre-malignant colorectal adenoma from a patient with familial polyposis coli (also referred to as hereditary adenomatosis of the colon and rectum) has become immortal in vitro. PCIAA has been passaged in vitro continuously
A critical step in the metastatic spread of tumour cells is the interaction of circulating tumour cells with the vascular endothelium. We have investigated the role of CD44 and its variants in the adhesion of a human melanoma cell line (RPMI-795 I) and a breast adenocarcinoma cell line (MDA-MB-23 I)